CV Risk Estimation

Joshua Steinberg MD

Veröffentlicht von: United Health Services

Beschreibung

This app is for CLINICIANS, not the lay public. The CV Risk app presents clinicians with three valuable 10-year cardiovascular event risk calculators to serve clinicians and learners in primary prevention of cardiovascular disease. It is for clinicians only, not the lay public. The calculators are Framingham 2008, ASCVD 2013, and the revised pooled cohort equations ASCVD of 2018.
The app addresses such common questions as:
• What is the ASCVD 10-year CV risk for a 57 year old male hypertensive smoker with a given set of lipid and blood pressure numbers?
• What’s the magnitude of impact of a patient on their own improving their cholesterol by 11, 27, or 41 points?
• For a poorly controlled hypertensive smoker with a 10-year risk of 31.3%, how impactful would improved blood pressure control or smoking cessation be?
• How impactful is a cholesterol of 220 on a given patient's risk at 35 vs. 55 vs. 75 years old?
• I hear that ASCVD 2013 overestimates risk, particularly for black adults? True? What about the revised pooled cohort equations of 2018?
The app explicitly does not include treatment thresholds, LDL targets, estimates of impact of therapy, coronary calcium scoring, etc. I wanted the cleanest simplest tool possible for evaluating and discussing cardiovascular risk with all the other more subjective, controversial stuff out of the way.
This app is written and intended for practicing clinicians like internists and family physicians; for resident physician trainees; for medical students; and of course for other clinician colleagues like NP's and PA's. Cardiologists could use this app, but you folks are focused on secondary prevention, which is an entirely different ballgame. As an educator and clinician, I am interested in feedback and I would be grateful for guidance on improving the tool.
Ausblenden Mehr anzeigen...

Screenshots

CV Risk Estimation Häufige Fragen

  • Ist CV Risk Estimation kostenlos?

    Ja, CV Risk Estimation ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist CV Risk Estimation seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet CV Risk Estimation?

    CV Risk Estimation ist kostenlos.

  • Wie hoch ist der Umsatz von CV Risk Estimation?

    Um geschätzte Einnahmen der CV Risk Estimation-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Libanon noch nicht bewertet.
Bewertungsverlauf

CV Risk Estimation Bewertungen

Good Tools

Rgrony on

Vereinigte Staaten

I like the access to three of the most used CV risk tools (Framingham, ASCVD 13, and Revised PCE). Straight forward and easy to use. However, I do disagree with the developer’s/author assessment of CAC testing. More and more evidence is showing that this will be a valuable tool in CV risk assessment. Most of the push back for this testing seems to be the result of insurance companies not wanting to cover the cost. Still….a good app.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

CV Risk Estimation Konkurrenten

Name
WarfarinGuide
BMC MAT Quick Start
Addiction Treatment Tools
Creda Health
Chronic Condition Management
N/V
calculators & decision support
ABFM CKSA
Prevent Group B Strep(GBS)
Waco Guide- Psychopharmacology
Clinical Decision Support
PFT eval
guidance on spirometry & PFT's
CV Risk Calc
Cardiovascular Risk Calculator
Aspirin Guide

CV Risk Estimation Installationen

Letzte 30 Tage

CV Risk Estimation Umsatz

Letzte 30 Tage

CV Risk Estimation Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von CV Risk Estimation mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.